| Identification | Back Directory | [Name]
Benzenesulfonamide, 3-(4-benzoyl-2-ethyl-2,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)- | [CAS]
2232890-86-5 | [Synonyms]
TK4g Benzenesulfonamide, 3-(4-benzoyl-2-ethyl-2,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)- | [Molecular Formula]
C19H19N3O4S | [MOL File]
2232890-86-5.mol | [Molecular Weight]
385.44 |
| Hazard Information | Back Directory | [Uses]
TK4g is a Janus kinase (JAK) inhibitor with the IC50 values of 12.61 nM and 15.80 nM for JAK2 and JAK3, respectively. TK4g can be used in lymphoid-derived diseases and leukemia cancer research[1]. | [IC 50]
JAK2: 12.61 nM (IC50); JAK3: 15.80 nM (IC50) | [References]
[1] Kamonpan Sanachai, et al. Pharmacophore-Based Virtual Screening and Experimental Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases. ACS Omega 2022. |
|
|